Due to this dual mode of action of the H4R, the development of H4R antagonists has lately emerged as a new promising treatment option for AD patients in clinical trials and therefore substantiated the importance of research on the role of the H4R, especially in inflammatory and allergic diseases [7,8]. Here, HRH4 is linked to allergic disease.